Similar articles

• [Longitudinal EEG study of uremic patients treated by extracorporeal hemodialysis and by intermittent peritoneal dialysis].

  Zysno E, Reichenmiller HE, Durr F. Zysno E, et al. Rev Neurol (Paris). 1967 Jul;117(1):128-30. Rev Neurol (Paris). 1967. PMID: 6063847 French. No abstract available.
• Electrophysiological and neurobehavioral responses to therapy: the National Cooperative Dialysis Study.

  Teschan PE, Bourne JR, Reed RB, Ward JW. Teschan PE, et al. Kidney Int Suppl. 1983 Apr;(13):S58-65. Kidney Int Suppl. 1983. PMID: 6101260 Clinical Trial. No abstract available.
• [Practical method and problems encountered in 10 cases of terminal chronic uremia treated by a long-term hemodialysis program].

  Nakajima K, Sakamoto Y. Nakajima K, et al. Naika. 1967 Oct;20(4):655-64. Naika. 1967. PMID: 5588536 Japanese. No abstract available.
• [Uremic coma from the viewpoints of modern therapy].

  Baethke R, Scholz A. Baethke R, et al. Internist (Berl). 1969 Nov;10(11):419-20. Internist (Berl). 1969. PMID: 4906538 Review. German. No abstract available.
• 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.

  Brandi L. Brandi L. Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.